Showing 341-350 of 353 grants

Title Institution Researcher Program Duration Total Award Amount
Role of oxidative post-translational modifications in generating neoepitopes Weill Medical College of Cornell University Laura Santambrogio Cures 01-April-2025 to 31-March-2028 $600.000,00
Co-transplantation of adaptive human endothelium and islets within encapsulated angiogenic hydrogels for durable engraftment Weill Medical College of Cornell University Shahin Rafii Cures 01-December-2023 to 30-November-2026 $1.000.000,00
Deriving Functional, Mature hPSC-derived Islet Organoids for Subcutaneous Transplantation Weill Medical College of Cornell University Shuibing Chen Cures 01-October-2026 to 30-September-2028 $699.998,58
Chemical Perturb-seq to identify small molecules controlling the maturation and survival on human beta cells Weill Medical College of Cornell University Xiaoshan Zhang Cures 01-March-2026 to 28-February-2029 $256.285,00
Localized immunomodulation for long term survival of beta islets in nonhuman primates William Marsh Rice University Omid Veiseh Cures 01-May-2026 to 30-April-2028 $2.013.056,40
Spatial and temporal regulation of proangiogenic factors to support islet cell transplantation William Marsh Rice University Omid Veiseh Cures 01-January-2025 to 31-December-2027 $900.000,00
Phenotyping RElatives of persons with Diabetes with CGM and Tests of beta-cell function and health (PREDICT): an integrated longitudinal assessment of deep metabolic phenotyping and CGM metrics in youth at risk for T1D Yale University Alfonso Galderisi Cures 01-February-2023 to 30-September-2026 $747.380,88
Genetic dissection of GLP1R signaling in type 1 diabetes outcomes Yale University David Alagpulinsa Improving Lives 01-April-2026 to 31-March-2027 $180.829,34
Genetic variation in RPS26 modulates beta-cell vitality and immunogenicity in type 1 diabetes Yale University David Alagpulinsa Cures 01-April-2026 to 31-March-2027 $199.959,68
Harnessing hematopoietic function in acute lymphoblastic leukemia to treat type 1 diabetes Yale University David Alagpulinsa Cures 01-March-2025 to 28-February-2030 $991.634,17